Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain Syndrome

The serratus anterior muscle is commonly involved in myofascial pain syndrome and is treated with many different injective methods. Currently, there is no definite injection point for the muscle. This study provides a suggestion for injection points for the serratus anterior muscle considering the i...

Full description

Bibliographic Details
Main Authors: Kyu-Ho Yi, Ji-Hyun Lee, Hee-Jin Kim
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Toxins
Subjects:
Online Access:https://www.mdpi.com/2072-6651/14/4/271
_version_ 1797409137994235904
author Kyu-Ho Yi
Ji-Hyun Lee
Hee-Jin Kim
author_facet Kyu-Ho Yi
Ji-Hyun Lee
Hee-Jin Kim
author_sort Kyu-Ho Yi
collection DOAJ
description The serratus anterior muscle is commonly involved in myofascial pain syndrome and is treated with many different injective methods. Currently, there is no definite injection point for the muscle. This study provides a suggestion for injection points for the serratus anterior muscle considering the intramuscular neural distribution using the whole-mount staining method. A modified Sihler method was applied to the serratus anterior muscles (15 specimens). The intramuscular arborization areas were identified in terms of the anterior (100%), middle (50%), and posterior axillary line (0%), and from the first to the ninth ribs. The intramuscular neural distribution for the serratus anterior muscle had the largest arborization patterns in the fifth to the ninth rib portion of between 50% and 70%, and the first to the fourth rib portion had between 20% and 40%. These intramuscular neural distribution-based injection sites are in relation to the external anatomical line for the frequently injected muscles to facilitate the efficiency of botulinum neurotoxin injections. Lastly, the intramuscular neural distribution of serratus anterior muscle should be considered in order to practice more accurately without the harmful side effects of trigger-point injections and botulinum neurotoxin injections.
first_indexed 2024-03-09T04:09:59Z
format Article
id doaj.art-c4ef8fa6e12442a990c0be9185a526e5
institution Directory Open Access Journal
issn 2072-6651
language English
last_indexed 2024-03-09T04:09:59Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj.art-c4ef8fa6e12442a990c0be9185a526e52023-12-03T14:01:57ZengMDPI AGToxins2072-66512022-04-0114427110.3390/toxins14040271Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain SyndromeKyu-Ho Yi0Ji-Hyun Lee1Hee-Jin Kim2COVID-19 Division, Wonju City Public Health Center, Wonju-si 26417, KoreaDivision in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, College of Dentistry, Yonsei University, Seoul 03722, KoreaDivision in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, College of Dentistry, Yonsei University, Seoul 03722, KoreaThe serratus anterior muscle is commonly involved in myofascial pain syndrome and is treated with many different injective methods. Currently, there is no definite injection point for the muscle. This study provides a suggestion for injection points for the serratus anterior muscle considering the intramuscular neural distribution using the whole-mount staining method. A modified Sihler method was applied to the serratus anterior muscles (15 specimens). The intramuscular arborization areas were identified in terms of the anterior (100%), middle (50%), and posterior axillary line (0%), and from the first to the ninth ribs. The intramuscular neural distribution for the serratus anterior muscle had the largest arborization patterns in the fifth to the ninth rib portion of between 50% and 70%, and the first to the fourth rib portion had between 20% and 40%. These intramuscular neural distribution-based injection sites are in relation to the external anatomical line for the frequently injected muscles to facilitate the efficiency of botulinum neurotoxin injections. Lastly, the intramuscular neural distribution of serratus anterior muscle should be considered in order to practice more accurately without the harmful side effects of trigger-point injections and botulinum neurotoxin injections.https://www.mdpi.com/2072-6651/14/4/271myofascial pain syndromeSihler’s methodserratus anteriortrigger point injection
spellingShingle Kyu-Ho Yi
Ji-Hyun Lee
Hee-Jin Kim
Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain Syndrome
Toxins
myofascial pain syndrome
Sihler’s method
serratus anterior
trigger point injection
title Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain Syndrome
title_full Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain Syndrome
title_fullStr Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain Syndrome
title_full_unstemmed Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain Syndrome
title_short Intramuscular Neural Distribution of the Serratus Anterior Muscle: Regarding Botulinum Neurotoxin Injection for Treating Myofascial Pain Syndrome
title_sort intramuscular neural distribution of the serratus anterior muscle regarding botulinum neurotoxin injection for treating myofascial pain syndrome
topic myofascial pain syndrome
Sihler’s method
serratus anterior
trigger point injection
url https://www.mdpi.com/2072-6651/14/4/271
work_keys_str_mv AT kyuhoyi intramuscularneuraldistributionoftheserratusanteriormuscleregardingbotulinumneurotoxininjectionfortreatingmyofascialpainsyndrome
AT jihyunlee intramuscularneuraldistributionoftheserratusanteriormuscleregardingbotulinumneurotoxininjectionfortreatingmyofascialpainsyndrome
AT heejinkim intramuscularneuraldistributionoftheserratusanteriormuscleregardingbotulinumneurotoxininjectionfortreatingmyofascialpainsyndrome